who should not take glp 1 receptor agonists GLP-1 MYTH BUSTER #1 “Weight-loss injections

Unexpected adverse events should be reported to the FDA MedWatch program

It is a proven adjunctive therapy for COPD, bronchiectasis, and cystic fibrosis

Her coronary artery calcium score was 280 and LDL was 168, up almost 100 points since she had stopped taking her statin

HFD-fed ATGL a dipoCre mice treated with G49 for 1 week presented attenuated body weight loss than their vehicle-treated controls (ATGL flox/flox ) (8.7 0.93% versus 16.2 0.82%) without reduction in adiposity (Fig

For patients with type 2 diabetes, the American Diabetes Association recommends checking HbA1c every three months until glycemic targets are achieved, then at least twice yearly thereafter

This conjugation process transforms lipophilic toxins into water-soluble glutathione adducts that can be efficiently eliminated through bile or urine